Accordingly, to verify these two hypotheses, this study aimed to investigate the difference between BM and PB NGAL levels and analyze the association of PB NGAL levels with hematologic parameters, including neutrophil count, in patients with hematologic malignancies. The gene discussed is LCN2; the disease is hematologic disorder.